The activation of SREBP-1c triggers the expression of genes responsible for encoding enzymes that mediate hepatic glycogen and triglyceride synthesis, suggesting the potential role of SREBP-1c in the progression of NAFLD [18]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.